Frequent downregulation of the runt domain transcription factors RUNX1, RUNX3 and their cofactor CBFB in gastric cancer
暂无分享,去创建一个
Susumu Nakashima | Yoshiaki Ito | Tsutomu Chiba | Akeo Hagiwara | Shujiro Yazumi | Koji Miyagawa | C. Sakakura | A. Hagiwara | T. Chiba | Yoshiaki Ito | H. Yamagishi | Hisakazu Yamagishi | Kosei Ito | Shuichi Kin | Tetsuji Yoshikawa | Koji Miyagawa | S. Nakashima | T. Yoshikawa | S. Kin | Y. Nakase | S. Yazumi | Kosei Ito | Chouhei Sakakura | Yuenn Nakase
[1] Y. Okazaki,et al. Overexpression of dopa decarboxylase in peritoneal dissemination of gastric cancer and its potential as a novel marker for the detection of peritoneal micrometastases with real-time RT–PCR , 2004, British Journal of Cancer.
[2] 吉田 カロリーナ アンドレア. Core-binding factor β interacts with Runx2 and is required for skeletal development , 2004 .
[3] Ph.D. Eiichi Tahara M.D.,et al. Molecular biology of gastric cancer , 2004, World Journal of Surgery.
[4] Y. Yuasa. Control of gut differentiation and intestinal-type gastric carcinogenesis , 2003, Nature Reviews Cancer.
[5] G. Stein,et al. Osteoblast-related transcription factors Runx2 (Cbfa1/AML3) and MSX2 mediate the expression of bone sialoprotein in human metastatic breast cancer cells. , 2003, Cancer research.
[6] Izhak Haviv,et al. Distinctive patterns of gene expression in premalignant gastric mucosa and gastric cancer. , 2003, Cancer research.
[7] J. Coffman. Runx transcription factors and the developmental balance between cell proliferation and differentiation , 2003, Cell biology international.
[8] K. Blyth,et al. The Runx genes as dominant oncogenes. , 2003, Blood cells, molecules & diseases.
[9] K. Miyazono,et al. RUNX transcription factors as key targets of TGF-β superfamily signaling , 2003 .
[10] M. Giphart-Gassler,et al. Identification of RUNX1/AML1 as a classical tumor suppressor gene , 2003, Oncogene.
[11] K. Miyazono,et al. RUNX transcription factors as key targets of TGF-beta superfamily signaling. , 2003, Current opinion in genetics & development.
[12] K. Blyth,et al. Proviral insertion indicates a dominant oncogenic role for Runx1/AML-1 in T-cell lymphoma. , 2002, Cancer research.
[13] M. Tatematsu,et al. Inhibition of growth of mouse gastric cancer cells by Runx3, a novel tumor suppressor , 2002, Oncogene.
[14] Y. Hayashizaki,et al. Differential gene expression profiles of gastric cancer cells established from primary tumour and malignant ascites , 2002, British Journal of Cancer.
[15] S. Itohara,et al. Causal Relationship between the Loss of RUNX3 Expression and Gastric Cancer , 2002, Cell.
[16] A. Lund,et al. RUNX: a trilogy of cancer genes. , 2002, Cancer cell.
[17] Kathryn E. Crosier,et al. Pathways in blood and vessel development revealed through zebrafish genetics. , 2002, The International journal of developmental biology.
[18] Motomi Osato,et al. Point Mutations of the RUNX1/AML1 Gene in Sporadic and Familial Myeloid Leukemias , 2001, International journal of hematology.
[19] F. Calabi,et al. Identification and comparative analysis of a second runx3 promoter. , 2001, Gene.
[20] Yoshiaki Ito,et al. Dimerization with PEBP2β protects RUNX1/AML1 from ubiquitin–proteasome‐mediated degradation , 2001, The EMBO journal.
[21] E. Kuipers,et al. Helicobacter pylori‐related and ‐non‐related gastric cancers do not differ with respect to chromosomal aberrations , 2000, The Journal of pathology.
[22] J. Bushweller. CBF--a biophysical perspective. , 2000, Seminars in cell & developmental biology.
[23] S. Le,et al. Transcription-Coupled Translation Control of AML1/RUNX1 Is Mediated by Cap- and Internal Ribosome Entry Site-Dependent Mechanisms , 2000, Molecular and Cellular Biology.
[24] E. Furth,et al. Altered gastric epithelial cell kinetics in Helicobacter pylori‐associated intestinal metaplasia: Implications for gastric carcinogenesis , 2000, International journal of cancer.
[25] John M. Maris,et al. Haploinsufficiency of CBFA2 causes familial thrombocytopenia with propensity to develop acute myelogenous leukaemia , 1999, Nature Genetics.
[26] S. H. Lee,et al. Frequent somatic mutations of the beta-catenin gene in intestinal-type gastric cancer. , 1999, Cancer research.
[27] H. Yamasaki,et al. Biallelic and heterozygous point mutations in the runt domain of the AML1/PEBP2alphaB gene associated with myeloblastic leukemias. , 1999, Blood.
[28] Y. Kanno,et al. Cytoplasmic Sequestration of the Polyomavirus Enhancer Binding Protein 2 (PEBP2)/Core Binding Factor α (CBFα) Subunit by the Leukemia-Related PEBP2/CBFβ-SMMHC Fusion Protein Inhibits PEBP2/CBF-Mediated Transactivation , 1998, Molecular and Cellular Biology.
[29] Anthony E. Reeve,et al. E-cadherin germline mutations in familial gastric cancer , 1998, Nature.
[30] Y. Kanno,et al. Cytoplasmic sequestration of the polyomavirus enhancer binding protein 2 (PEBP2)/core binding factor alpha (CBFalpha) subunit by the leukemia-related PEBP2/CBFbeta-SMMHC fusion protein inhibits PEBP2/CBF-mediated transactivation. , 1998, Molecular and cellular biology.
[31] M. Owen,et al. Mutations Involving the Transcription Factor CBFA1 Cause Cleidocranial Dysplasia , 1997, Cell.
[32] S. Mundlos,et al. Cbfa1, a Candidate Gene for Cleidocranial Dysplasia Syndrome, Is Essential for Osteoblast Differentiation and Bone Development , 1997, Cell.
[33] Makoto Sato,et al. Targeted Disruption of Cbfa1 Results in a Complete Lack of Bone Formation owing to Maturational Arrest of Osteoblasts , 1997, Cell.
[34] T. Noda,et al. Hematopoiesis in the fetal liver is impaired by targeted mutagenesis of a gene encoding a non-DNA binding subunit of the transcription factor, polyomavirus enhancer binding protein 2/core binding factor. , 1997, Proceedings of the National Academy of Sciences of the United States of America.
[35] S. Nishizuka,et al. Commonly deleted regions on the long arm of chromosome 21 in differentiated adenocarcinoma of the stomach , 1997, Genes, chromosomes & cancer.
[36] R. Bronson,et al. Absence of fetal liver hematopoiesis in mice deficient in transcriptional coactivator core binding factor beta. , 1996, Proceedings of the National Academy of Sciences of the United States of America.
[37] S. Hirohashi,et al. E‐Cadherin Gene Mutations in Signet Ring Cell Carcinoma of the Stomach , 1996, Japanese journal of cancer research : Gann.
[38] T Takahashi,et al. Overexpression of bax sensitizes human breast cancer MCF‐7 cells to radiation‐induced apoptosis , 1996, International journal of cancer.
[39] M. Marín‐Padilla,et al. Disruption of the Cbfa2 gene causes necrosis and hemorrhaging in the central nervous system and blocks definitive hematopoiesis. , 1996, Proceedings of the National Academy of Sciences of the United States of America.
[40] J. Downing,et al. AML1, the Target of Multiple Chromosomal Translocations in Human Leukemia, Is Essential for Normal Fetal Liver Hematopoiesis , 1996, Cell.
[41] H. Espejo,et al. [Gastric cancer]. , 1996, Revista de gastroenterologia del Peru : organo oficial de la Sociedad de Gastroenterologia del Peru.
[42] Y. Yamaguchi-Iwai,et al. Growth inhibition and induction of differentiation of t(8;21) acute myeloid leukemia cells by the DNA-binding domain of PEBP2 and the AML1/MTG8(ETO)-specific antisense oligonucleotide. , 1994, Proceedings of the National Academy of Sciences of the United States of America.
[43] M. Sporn,et al. Genetic changes in the transforming growth factor beta (TGF-beta) type II receptor gene in human gastric cancer cells: correlation with sensitivity to growth inhibition by TGF-beta. , 1994, Proceedings of the National Academy of Sciences of the United States of America.
[44] F. Collins,et al. Fusion between transcription factor CBF beta/PEBP2 beta and a myosin heavy chain in acute myeloid leukemia. , 1993, Science.
[45] Y. Ito,et al. PEBP2/PEA2 represents a family of transcription factors homologous to the products of the Drosophila runt gene and the human AML1 gene. , 1993, Proceedings of the National Academy of Sciences of the United States of America.
[46] M. Ohki,et al. The t(8;21) translocation in acute myeloid leukemia results in production of an AML1‐MTG8 fusion transcript. , 1993, The EMBO journal.
[47] Yoshiaki Ito,et al. Molecular Cloning and Characterization of PEBP2β, the Heterodimeric Partner of a Novel Drosophila runt-Related DNA Binding Protein PEBP2α , 1993 .
[48] J. Rowley,et al. Detection of DNA rearrangements in the AML1 and ETO loci and of an AML1/ETO fusion mRNA in patients with t(8;21) acute myeloid leukemia. , 1993, Blood.
[49] Y. Ito,et al. Molecular cloning and characterization of PEBP2 beta, the heterodimeric partner of a novel Drosophila runt-related DNA binding protein PEBP2 alpha. , 1993, Virology.
[50] M. Ohki,et al. t(8;21) breakpoints on chromosome 21 in acute myeloid leukemia are clustered within a limited region of a single gene, AML1. , 1991, Proceedings of the National Academy of Sciences of the United States of America.
[51] M. Maltoni,et al. Heterogeneous protooncogene amplification correlates with tumor progression and presence of metastases in gastric cancer patients. , 1990, Cancer research.